Company: DARE
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001493152-25-006958
Chunk: 1

Company: Dare Bioscience, Inc.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 3.01
Chunk 1
---
 continued listing of the Company’s common stock on The Nasdaq Capital Market. Investors are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date of this report. The Company undertakes no obligation to
update any forward-looking statement in this report, except as required by law.

  -2-  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                         DARÉ                                               
  Dated:                 By:                   /s/                          
                         Name:                 Sabrina                      
                         Title:                President                    

  -3-